Outcome of Board Meeting held on 29.05.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jeevan Scientific Technology Limited reported strong FY2026 results with standalone revenue growing 23.7% to Rs 5,393 lakhs and consolidated revenue up 31.3% to Rs 6,154 lakhs. Standalone profit after tax jumped 124% to Rs 165 lakhs, while consolidated PAT rose significantly from Rs 5.9 lakhs to Rs 103 lakhs. The Board approved audited results with an unmodified audit opinion from Pavuluri & Co. Additionally, 480,000 new stock options were granted to employees under the JSTL ESOP Scheme 2016, and 161,250 equity shares were allotted to employees who exercised their options at Rs 10 per share. M/s KP & Associates was appointed as internal auditors for FY2026-27. The company's paid-up capital increased to Rs 19.92 crore after the ESOP allotment.
The company showed robust revenue and profit growth, and the clean audit opinion with no qualifications provides confidence to shareholders. ESOP grants align employee interests with shareholders while the share allotment has a modest dilutive effect.